Yan Zechen, Meng Qingjun, Yang Jinjian, Zhang Junjie, Zhao Wei, Guo Fei, Song Dongjian, Zhan Yuxiao, Fan Dandan, Zhou Ruiyi, Zuo Shuqiang, Wang Zehua, Yu Jiekai, Zheng Shu, Wang Jiaxiang
Department of Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Henan Academy of Medical and Parmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Oncol Lett. 2016 Dec;12(6):5075-5079. doi: 10.3892/ol.2016.5306. Epub 2016 Oct 21.
Wilms tumor (WT) is the most common cancer that primarily develops in abdominal solid organ of children. It has no incipient symptom, and the most frequent symptoms are a painless, palpable abdominal mass. Proteomics technology was used to select the differentially expressed proteins of bilateral Wilms tumor (BWT). Ten serum samples of children with BWT were chosen, 20 serum samples of children with unilateral WT (UWT) and 20 serum samples of healthy children were selected, and proteomics technology was used to detect and collect data. Using bioinformatics, the data were analyzed and 10 difference peaks were obtained (P<0.01). Non-linear support vector machine was used to classify and to select the composite pattern with the highest Youdens index, and one differentially expressed protein with m/z of 5,648 kDa was obtained. A significantly high expression in children with BWT was obtained, and the expression intensity was also significantly (3,889.36±1,796.83) higher for children with BWT compared to those with UWT (2,886.81±1,404.65) and healthy children (432.21±730.42). Matrix-assisted laser desorption ionization/time-of-flight ionization/time-of-flight mass spectrometry was used for identification of the peak, and the peak was further identified as apolipoprotein C-III (APO C-III) by western blot analysis. In conclusion, to the best of our knowledge, a differentially expressed protein of APO C-III of BWT was obtained through proteomics technology for the first time, and it is expected to be a new marker for the early diagnosis and prognosis of BWT.
肾母细胞瘤(WT)是儿童腹部实体器官中最常见的癌症。它没有初期症状,最常见的症状是无痛性、可触及的腹部肿块。采用蛋白质组学技术筛选双侧肾母细胞瘤(BWT)中差异表达的蛋白质。选取10例BWT患儿的血清样本、20例单侧WT(UWT)患儿的血清样本和20例健康儿童的血清样本,运用蛋白质组学技术进行检测并收集数据。利用生物信息学对数据进行分析,获得10个差异峰(P<0.01)。采用非线性支持向量机进行分类,并选择约登指数最高的复合模式,得到一个质荷比为5648 kDa的差异表达蛋白。该蛋白在BWT患儿中表达显著升高,与UWT患儿(2886.81±1404.65)和健康儿童(432.21±730.42)相比,BWT患儿的表达强度也显著更高(3889.36±1796.83)。采用基质辅助激光解吸电离/飞行时间质谱对该峰进行鉴定,并通过蛋白质印迹分析进一步确定该峰为载脂蛋白C-III(APO C-III)。综上所述,据我们所知,首次通过蛋白质组学技术获得了BWT差异表达的APO C-III蛋白,有望成为BWT早期诊断和预后的新标志物。